Background:
Enrofloxacin (ENR) is a fluoroquinolone antibiotic approved for use in sheep of all
ages. The body composition and metabolic capability change with age. These changes may alter the pharmacokinetics
of drugs and thus their effect. Therefore, the pharmacokinetics of drugs need to be established in target-
age animals
Objective:
To determine the pharmacokinetics of ENR and its active metabolite, ciprofloxacin (CIP), following
a single intravenous administration of ENR at a dose of 10 mg/kg in different ages of sheep.
Methods:
The study was carried out in the one-, six- and twelve-month age period of the sheep. A single dose
of 10 mg/kg ENR was administered intravenously through the jugular vein to sheep in all age periods. ENR
and CIP plasma concentrations were determined using HPLC–UV and analyzed using a non-compartmental
method.
Results:
ENR was detected in the plasma until 36 h in one-month-old and up to 24 h in other ages. CIP was detected
in the plasma up to 24 h in all age groups. The t1/2ʎz and Vdss were significantly higher in one-month-old
sheep than in six and twelve-months old sheep. There was no difference in ClT and AUC values in different
age groups. AUC0-∞CIP/AUC0-∞ENR ratios were higher in one-month-old than in six- and twelve-months sheep.
Conclusion:
The most important pharmacokinetic changes associated with aging in sheep are decreased Vdss
and t1/2ʎz of ENR and the low ratio metabolizing of ENR to CIP. Pharmacokinetic/pharmacodynamic data
showed that ENR after IV administration of 10 mg/kg dose provided the optimal AUC0–24/MIC90 ratios for E.
coli, P. multocida and Mycoplasma spp. (>125) with MIC of 0.37 μg/mL and for S. aureus (>30) with MIC of
0.5 μg/mL in all ages of sheep.